Abivax shares dropped significantly after new clinical trial data for its ulcerative colitis drug revealed cancer concerns, impacting its future.
Read More
The Geo Chronicle
Your Window to World Affairs
YOU MAY HAVE MISSED
Your Window to World Affairs
Abivax shares dropped significantly after new clinical trial data for its ulcerative colitis drug revealed cancer concerns, impacting its future.
Read More